Skip to main content
Erschienen in: Clinical Autonomic Research 1/2020

02.01.2019 | Research Article

The Orthostatic Discriminant and Severity Scale (ODSS): an assessment of orthostatic intolerance

verfasst von: Jacquie Baker, Justin R. Paturel, David M. Sletten, Phillip A. Low, Kurt Kimpinski

Erschienen in: Clinical Autonomic Research | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the ability of the Orthostatic Discriminant and Severity Scale (ODSS) to distinguish symptoms of orthostatic intolerance from non-orthostatic symptoms.

Methods

Clinical evaluations and questionnaire responses were collected in 73 healthy controls and 132 patients referred to the Autonomic Disorders Clinic from September 1, 2016, through April 30, 2018, for queries regarding autonomic dysfunction. A receiver operating characteristic (ROC) curve analysis was used to interpret sensitivity and specificity and to determine cutoff scores for symptom assessment. Inter-item reliability was assessed using Cronbach’s alpha. To calculate positive and negative predictive powers, patient data were collected in a single-blinded fashion where the researcher collecting questionnaire data was blinded to the clinical evaluation and diagnosis. Predictive powers were calculated using a chi-squared cross-tabulation.

Results

The orthostatic and non-orthostatic symptoms scores produced ROC curves with an area under the curve of 0.89 and 0.79, respectively. The orthostatic scores yielded a positive and negative predictive power value of 73% and 81%, respectively. Combined, the ODSS identified patients with and without orthostatic symptoms with an overall accuracy of 76%. The reliability of the ODSS was significant, with a Cronbach’s alpha of 0.88, and all dichotomous items were deemed worthy of retention following an inter-item reliability assessment.

Conclusions

The ODSS demonstrated a strong ability to distinguish patients with and without orthostatic intolerance and demonstrated sensitivity and specificity equivalent to that of other standardized measures. Overall, the ODSS produces symptom scores that are both reliable and useful for both research and clinical practice.
Literatur
1.
Zurück zum Zitat Low P, Sandroni P, Joyner MJ, Shen W (2008) Postural tachycardia syndrome. In: Low PA, Benarroch EE (eds) Clinical autonomic disorders, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 515–533 Low P, Sandroni P, Joyner MJ, Shen W (2008) Postural tachycardia syndrome. In: Low PA, Benarroch EE (eds) Clinical autonomic disorders, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 515–533
2.
Zurück zum Zitat Lanier JB, Mote MB, Clay EC (2011) Evaluation and management of orthostatic hypotension. Am Fam Physicians 84:527–536 Lanier JB, Mote MB, Clay EC (2011) Evaluation and management of orthostatic hypotension. Am Fam Physicians 84:527–536
3.
Zurück zum Zitat Low P, Benarroch E (2008) Clinical autonomic disorders, 3rd edn. Lippincott Williams & Wilkins, Philadelphia Low P, Benarroch E (2008) Clinical autonomic disorders, 3rd edn. Lippincott Williams & Wilkins, Philadelphia
4.
Zurück zum Zitat Kimpinski K, Iodice V, Sandroni P, Low PA (2010) Postural tachycardia syndrome and pregnancy effect of pregnancy on postural tachycardia syndrome. Mayo Clin Proc 85:639–644CrossRefPubMedCentral Kimpinski K, Iodice V, Sandroni P, Low PA (2010) Postural tachycardia syndrome and pregnancy effect of pregnancy on postural tachycardia syndrome. Mayo Clin Proc 85:639–644CrossRefPubMedCentral
5.
Zurück zum Zitat Freeman R, Wieling W, Axelrod FB et al (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69–72CrossRef Freeman R, Wieling W, Axelrod FB et al (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69–72CrossRef
6.
Zurück zum Zitat Baker J, Kimpinski K (2017) Management of supine hypertension complicating neurogenic orthostatic hypotension. CNS Drugs 8:653–663CrossRef Baker J, Kimpinski K (2017) Management of supine hypertension complicating neurogenic orthostatic hypotension. CNS Drugs 8:653–663CrossRef
8.
Zurück zum Zitat Low P, Opfer-Gehrking TL (1999) The autonomic laboratory. Am J Electroneurodiagnostic Technol 39:65–76CrossRef Low P, Opfer-Gehrking TL (1999) The autonomic laboratory. Am J Electroneurodiagnostic Technol 39:65–76CrossRef
9.
Zurück zum Zitat Low P (1993) Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc 68:748–752CrossRef Low P (1993) Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc 68:748–752CrossRef
10.
Zurück zum Zitat Suarez G, Opfer-Gehrking TL, Offord K et al (1999) The autonomic symptom profile: a new instrument to assess autonomic symptoms. Neurology 52:523–528CrossRef Suarez G, Opfer-Gehrking TL, Offord K et al (1999) The autonomic symptom profile: a new instrument to assess autonomic symptoms. Neurology 52:523–528CrossRef
11.
Zurück zum Zitat Kaufmann H, Malamut R, Norcliffe-Kaufmann L et al (2012) The orthostatic hypotension questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res 22:79–90CrossRef Kaufmann H, Malamut R, Norcliffe-Kaufmann L et al (2012) The orthostatic hypotension questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res 22:79–90CrossRef
12.
Zurück zum Zitat Wenning GK, Tison F, Seppi K et al (2004) Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 19:1391–1402CrossRef Wenning GK, Tison F, Seppi K et al (2004) Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 19:1391–1402CrossRef
13.
Zurück zum Zitat Zilliox L, Peltier AC, Wren PA et al (2011) Assessing autonomic dysfunction in early diabetic neuropathy. Neurology 76:1099–1105CrossRefPubMedCentral Zilliox L, Peltier AC, Wren PA et al (2011) Assessing autonomic dysfunction in early diabetic neuropathy. Neurology 76:1099–1105CrossRefPubMedCentral
14.
Zurück zum Zitat Visser M, Marinus J, Stiggelbout AM, van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19:1306–1312CrossRef Visser M, Marinus J, Stiggelbout AM, van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19:1306–1312CrossRef
15.
Zurück zum Zitat Berger M, Kimpinski K (2014) A practical guide to the treatment of neurogenic orthostatic hypotension. Can J Neurol Sci 41:156–163CrossRef Berger M, Kimpinski K (2014) A practical guide to the treatment of neurogenic orthostatic hypotension. Can J Neurol Sci 41:156–163CrossRef
16.
Metadaten
Titel
The Orthostatic Discriminant and Severity Scale (ODSS): an assessment of orthostatic intolerance
verfasst von
Jacquie Baker
Justin R. Paturel
David M. Sletten
Phillip A. Low
Kurt Kimpinski
Publikationsdatum
02.01.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Autonomic Research / Ausgabe 1/2020
Print ISSN: 0959-9851
Elektronische ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-018-00586-5

Weitere Artikel der Ausgabe 1/2020

Clinical Autonomic Research 1/2020 Zur Ausgabe

Acknowledgement to Reviewers

Acknowledgement to reviewers

Neu in den Fachgebieten Neurologie und Psychiatrie

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.